Covid-19 variant in UK ‘likely to sweep the world’
Vaccines have been effective against variants in the UK so far, but mutations could potentially undermine the shots, a vaccines expert says
11 February 2021 - 12:06
byGuy Faulconbridge
Support our award-winning journalism. The Premium package (digital only) is R30 for the first month and thereafter you pay R129 p/m now ad-free for all subscribers.
London — The coronavirus variant first found in the British region of Kent is a concern because it could undermine the protection given by vaccines against developing Covid-19, the head of the UK’s genetic surveillance programme said.
She also said the variant was dominant in the country and was likely “to sweep the world, in all probability”.
The coronavirus has killed 2.35-million people and turned normal life upside down for billions, but a few new worrying variants out of thousands have raised fears that vaccines will need to be tweaked and people may require booster shots.
Sharon Peacock, director of the Covid-19 Genomics UK consortium, said vaccines were so far effective against the variants in the UK, but that mutations could potentially undermine the shots.
“What’s concerning about this is that the 1.1.7. variant that we have had circulating for some weeks and months is beginning to mutate again and get new mutations which could affect the way that we handle the virus in terms of immunity and effectiveness of vaccines,” Peacock told the BBC.
“It's concerning that the 1.1.7., which is more transmissible, which has swept the country, is now mutating to have this new mutation that could threaten vaccination.”
That new mutation, first identified in Bristol in southwest England, has been designated a “Variant of Concern”, by the New and Emerging Respiratory Virus Threats Advisory Group.
There are so far 21 cases of that variant which has E484K mutation, which occurs on the spike protein of the virus, the same change as has been seen in the SA and Brazilian variants.
“One has to be a realist that this particular mutation has arisen in our kind of communal garden lineage now, at least five times — five separate times. And so this is going to keep popping up,” Peacock said.
There are three major known variants that are worrying scientists: The variant prominent in SA, known by scientists as 20I/501Y.V2 or B. 1.351; the UK or Kent variant, known as 20I/501Y.V1 or B.1.1.7; and the Brazilian variant known as P.1.
The variant prominent in the UK, which is more infectious but not necessarily more deadly than others, was likely “to sweep the world”, Peacock said.
“Once we get on top of [the virus] or it mutates itself out of being virulent — causing disease — then we can stop worrying about it. But I think, looking in the future, we're going to be doing this for years. We're still going to be doing this 10 years down the line, in my view.”
The two Covid-19 vaccines developed by Pfizer/BioNTech and AstraZeneca protect against the main British variant.
Support our award-winning journalism. The Premium package (digital only) is R30 for the first month and thereafter you pay R129 p/m now ad-free for all subscribers.
Covid-19 variant in UK ‘likely to sweep the world’
Vaccines have been effective against variants in the UK so far, but mutations could potentially undermine the shots, a vaccines expert says
London — The coronavirus variant first found in the British region of Kent is a concern because it could undermine the protection given by vaccines against developing Covid-19, the head of the UK’s genetic surveillance programme said.
She also said the variant was dominant in the country and was likely “to sweep the world, in all probability”.
The coronavirus has killed 2.35-million people and turned normal life upside down for billions, but a few new worrying variants out of thousands have raised fears that vaccines will need to be tweaked and people may require booster shots.
Sharon Peacock, director of the Covid-19 Genomics UK consortium, said vaccines were so far effective against the variants in the UK, but that mutations could potentially undermine the shots.
“What’s concerning about this is that the 1.1.7. variant that we have had circulating for some weeks and months is beginning to mutate again and get new mutations which could affect the way that we handle the virus in terms of immunity and effectiveness of vaccines,” Peacock told the BBC.
“It's concerning that the 1.1.7., which is more transmissible, which has swept the country, is now mutating to have this new mutation that could threaten vaccination.”
That new mutation, first identified in Bristol in southwest England, has been designated a “Variant of Concern”, by the New and Emerging Respiratory Virus Threats Advisory Group.
There are so far 21 cases of that variant which has E484K mutation, which occurs on the spike protein of the virus, the same change as has been seen in the SA and Brazilian variants.
“One has to be a realist that this particular mutation has arisen in our kind of communal garden lineage now, at least five times — five separate times. And so this is going to keep popping up,” Peacock said.
There are three major known variants that are worrying scientists: The variant prominent in SA, known by scientists as 20I/501Y.V2 or B. 1.351; the UK or Kent variant, known as 20I/501Y.V1 or B.1.1.7; and the Brazilian variant known as P.1.
The variant prominent in the UK, which is more infectious but not necessarily more deadly than others, was likely “to sweep the world”, Peacock said.
“Once we get on top of [the virus] or it mutates itself out of being virulent — causing disease — then we can stop worrying about it. But I think, looking in the future, we're going to be doing this for years. We're still going to be doing this 10 years down the line, in my view.”
The two Covid-19 vaccines developed by Pfizer/BioNTech and AstraZeneca protect against the main British variant.
Reuters
Oxford research group on whether we need new Covid-19 vaccines
WHO recommends AstraZeneca’s Covid-19 shot even in countries with variant found in SA
Vaccinations likely to start next week as J&J’s research stock bridges gap
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Most Read
Related Articles
AstraZeneca’s vaccine useful despite new variants, says WHO
CHRIS GILMOUR: Vaccine passport vital to save travel industry during Covid-19
Push is on to get J&J vaccine moving
Published by Arena Holdings and distributed with the Financial Mail on the last Thursday of every month except December and January.